Rate of congenital toxoplasmosis in large integrated health care setting, California, USA, 1998-2012.

Rate of Congenital Toxoplasmosis, California

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.

Objective: To determine the safety of cold-adapted trivalent intranasal influenza virus vaccine (CAIV) in children and adolescents.

Study Design: A randomized, double blind, placebo-controlled safety trial in healthy children age 12 months to 17 years given CAIV (FluMist; MedImmune Vaccines, Inc.) or placebo (randomization, 2:1).